Takashi Ohtsuki Selected Research

Takashi Ohtsuki Research Topics

Disease

14	Neoplasms (Cancer) 02/2021 - 01/2004
4	Osteoarthritis 02/2022 - 12/2018
4	Adenocarcinoma 01/2011 - 08/2009
2	Infections 02/2022 - 03/2021
2	Fibrosis (Cirrhosis) 05/2018 - 12/2010
2	Leukemia 01/2007 - 01/2004
1	Chondrosarcoma 02/2022
1	Confusion (Bewilderment) 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2021
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 07/2021
1	COVID-19 03/2021
1	Lung Neoplasms (Lung Cancer) 08/2019
1	Insulin Resistance 05/2018
1	Hypertension (High Blood Pressure) 05/2018
1	Left Ventricular Dysfunction 05/2018
1	Stroke (Strokes) 05/2018
1	Neuroblastoma 03/2018
1	Neoplasm Metastasis (Metastasis) 12/2017
1	Cachexia 01/2017
1	Pneumonia (Pneumonitis) 01/2014
1	Leukemia P388 07/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2011
1	Hypoxia (Hypoxemia) 01/2011
1	Hypertrophy 12/2010
1	Carcinogenesis 04/2009
1	Colonic Neoplasms (Colon Cancer) 04/2009
1	Weight Loss (Weight Reduction) 03/2009
1	Body Weight (Weight, Body) 03/2009
1	MELAS Syndrome (Syndrome, MELAS) 07/2008

Drug/Important Bio-Agent (IBA)

4	ThrombospondinsIBA 02/2022 - 01/2017
4	Metalloproteases (Metalloproteinases)IBA 02/2022 - 01/2017
4	DisintegrinsIBA 02/2022 - 01/2017
4	Messenger RNA (mRNA)IBA 06/2020 - 08/2009
3	Pharmaceutical PreparationsIBA 02/2022 - 06/2020
3	CytokinesIBA 02/2022 - 10/2019
3	CannabidiolIBA 02/2022 - 03/2021
3	Small Interfering RNA (siRNA)IBA 07/2021 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 02/2022 - 10/2019
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 02/2021 - 01/2016
2	Photosensitizing Agents (Photosensitizers)IBA 02/2021 - 01/2016
2	NucleotidesIBA 06/2020 - 08/2019
2	DNA ProbesIBA 06/2020 - 08/2019
2	ErbB Receptors (EGF Receptor)IBA 06/2020 - 08/2019
2	Peptide Nucleic AcidsIBA 06/2020 - 08/2019
2	Hyaluronic Acid (Hyaluronan)IBA 04/2020 - 12/2018
2	SugarsIBA 03/2009 - 01/2004
2	Methanol (Carbinol)IBA 01/2007 - 01/2004
1	EnzymesIBA 02/2022
1	CannabinoidsIBA 01/2022
1	OsteopontinIBA 07/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 07/2021
1	7-hydroxycannabidiolIBA 03/2021
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 02/2021
1	AntigensIBA 02/2021
1	AcidsIBA 02/2021
1	Cell-Penetrating PeptidesIBA 02/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2021
1	MicellesIBA 02/2021
1	PorphyrinsIBA 02/2021
1	MesothelinIBA 02/2021
1	Single-Chain AntibodiesIBA 02/2021
1	Immunoglobulin G (IgG)IBA 02/2021
1	Therapeutic UsesIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 08/2019
1	Peptide Hydrolases (Proteases)FDA Link 06/2018
1	Dihydrotachysterol (AT 10)IBA 06/2018
1	GalactosidasesIBA 06/2018
1	Glucose (Dextrose)FDA LinkGeneric 05/2018
1	LipidsIBA 05/2018
1	CholesterolIBA 05/2018
1	MicroRNAs (MicroRNA)IBA 03/2018
1	Proteoglycans (Proteoglycan)IBA 12/2017
1	Versicans (Versican)IBA 12/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2014
1	Amino Acids FDA Link 07/2013
1	Green Fluorescent ProteinsIBA 01/2011
1	cryptolepineIBA 01/2011
1	Hydralazine (Apresoline)FDA LinkGeneric 12/2010
1	Connective Tissue Growth FactorIBA 12/2010
1	Proteins (Proteins, Gene)FDA Link 12/2010
1	olmesartanIBA 12/2010
1	Caspase 3 (Caspase-3)IBA 08/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010
1	TNF-Related Apoptosis-Inducing LigandIBA 03/2010
1	1,3,5,8- tetrahydroxy- 2,4- bis(3- methyl- 2- butenyl)xanthoneIBA 03/2010
1	Death Domain ReceptorsIBA 09/2009
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 08/2009
1	beta CateninIBA 04/2009
1	1- O- beta- D- glucopyranosyl- geraniol- 5,10- olideIBA 03/2009
1	Triglycerides (Triacylglycerol)IBA 03/2009
1	5-taurinomethyluridineIBA 07/2008
1	zerumboneIBA 12/2007

Therapy/Procedure

6	Therapeutics 02/2021 - 09/2009
1	Precision Medicine 02/2021
1	Photochemotherapy (Photodynamic Therapy) 02/2021
1	Oral Administration 03/2009